We applied the technique of mRNA differential display to normal liver tissue and hepatoma cell line Hep3B. One of the isolated cDNA clones was expressed in human normal liver tissue but not in the human hepatocarcinoma cell line. Northern Blot analysis confirmed that high level of mRNA was expressed in human normal liver tissue but the level was decreased in non-cancerous liver tissue from hepatoma patients. Low level or no expression was observed in human hepatoma tissue. One of these transcripts was about 1.8 kb in length. Southern Blot analysis showed that it was a single copy gene. We obtained a full length cDNA clone of 2,395 bp by screening human liver 5'-stretch plus cDNA library. Nucleotide sequence indicated that this clone was highly homologous to aryldialkyl-phosphatase and possessed two polymorphic sites. Aryl-dialkyl-phosphatase which has a prominent role in the metabolism of several toxic, synthetic compounds, may be potentially related to human hepatocarcinoma susceptibility. The biological significance of its differential expression in normal versus malignant tissue is discussed.
INTRODUCTION
Cancer is believed to be the result of cumulative multiple genetic aberrations and a process that may operate through either of two different mechanisms. The first mechanism involves a class of oncogenes and tumor suppressor genes, whose activation and/or inactivation is directly involved in tumorigenesis. The second mechanism involves a class of cancer susceptibility genes, which influence the rate at which mutations occur and/or accumulate. Cancer susceptibility genes are involved in DNA repair, phase I and II metabolism and so on. Variation of genes from class II, while not directly responsible for transformation, may act to alter genes categorized in class I. The aberrant expression of these critical genes and their downstream subsets of genes might enable a cell to proliferate out of control. To identify and characterize as many of these genes as possible has become crucial to understand the nature of the disease and to devise rational therapies and prevention.
Several important genes implicated in tumorigenesis have been isolated [1, 2] by mRNA differential display (mRNA DD) developed by P. Liang and A. Pardee in 1992[3, 4] . In 1993, our laboratory, in collaboration with Dr. Takis Papas, FCRDC, NCI, applied mRNA DD to identify and isolate a small subset of genes that are differentially expressed in normal liver tissue versus human hepatoma cell line Hep3B. By this method we have obtained 28 differentially expressed clones [5] . In this paper we report that one of these clones that is overexpressed in normal liver tissue and underexpressed in hepatocarcinoma tissue.
MATERIALS AND METHODS

Materials
Human liver 5'-stretch plus cDNA library was provided by CLONTECH Laboratories, Inc. Human primary hepatoma and corresponding non-cancerous liver tissues were collected from Qidong Cancer Institute. All the specimens were confirmed by histopathological examination. Nick translation DNA labeling kit, random primer labeling kit, Geneclean DNA purification kit and USB sequenase version 2.0 kit was obtained respectively from Boehringer Mannheim, Stratagene, BIO101 
Screening of cDNA library
Screening of cDNA library was performed with 32 P-(α )-dCTP labeled C2L2 probe at high stringency, hybridized overnight at 42 ℃ in 50% formamide / 6 × standard saline sodium citrate (SSC) / 5 × Denhardt's solution / 0.5% SDS / 200 mg of salmon sperm DNA and washed in 0.5 × SSC / 0.1% SDS at 42 ℃, 30 min, at 55 ℃, 1 h. After the third round of screening, twelve independent clones were isolated. The phage DNA was purified by liquid amplification and digested with EcoRI (cloning site). The inserts were confirmed by Southern blot and then subcloned into the pBluescript SK(-) vector 
Northern and Southern blot analysis
RESULT
Isolation of C2L2 clone
Human liver 5'-stretch plus cDNA library was screened by using C2L2 probe. After three rounds of screening, twelve positive phages that gave the strongest signal were purified by liquid amplification. Inserts were cleaved by restriction enzyme EcoRI, confirmed by subsequent Southern blot hybridization with C2L2 probe and finally subcloned into pBluescript SK(-) vector (Fig 1) .
Northern blot analysis
Northern blot analysis was carried out in 4 samples of normal human liver tissue and in 6 pairs of samples from human primary hepatic cancer and its surrounding non-cancerous hepatic tissues. It was demonstrated that this gene was expressed more strongly in normal liver tissues than in surrounding non-cancerous hepatic tissues, and its expression was low or absent in hepatoma tissues. Moreover, a single hybridization band was observed, corresponding to a transcript of approximately 1.8 kb (Fig 2) .
Southern blot analysis
Genomic DNA extracted from human liver, hepatic cancer and surrounding noncancerous tissues was digested with PstI and EcoRI respectively. Fig 3 showed that only one hybridization band was observed at about 3 or 4 kb respectively in each restriction digested lane. These data suggested that this gene was probably of a single copy entity. The positive bands from both normal liver and hepatoma tissues were located at the same position. These findings indicated that C2L2 gene was not lost or grossly aberrant in hepatic cancer tissue, but the existence of subtle genomic alterations could not yet be excluded from the present data. 
Sequencing of the C2L2 cDNA clone
The C2L2 cDNA clone contained 2,395 base pairs, covering the entire protein coding sequence (Fig 4) . Fifty-four nucleotides preceded the codon ATG which initiated an open reading frame coding for 355 amino acids. A stop codon, TAA, was followed by an additional 1,276 nucleotides of 3' non-coding sequence. The ATG at position 1 was likely the start position since there was a stop codon beginning 36 nncleotides upstream from this ATG. Poly(A) signal (AATAAA) was located at nt 2,052. There were two polymorphic sites in the sequence. One was located at nt 217 with A or T (Fig 5A) , and the other at nt 629 with G of A (Fig 5B) .
61 AAG CTG ATT GCG CTC ACC CTC TTG GGG ATG GGA CTG GCA CTC TTC AGG AAC CAC CAG TCT 120
121 TCT TAC CAA ACA CGA CTT AAT GCT CTC CGA GAG GTA CAA CCC GTA GAA CTT CCT AAC TGT 180
181 AAT TTA GTT AAA GGA ATC GAA ACT GGC TCT GAA GAC T/A TG GAG ATA CTG CCT AAT GGA CTG 240
241 GCT TTC ATT AGC TCT GGA TTA AAG TAT CCT GGA ATA AAG AGC TTC AAC CCC AAC AGT CCT 300
301 GGA AAA ATA CTT CTG ATG GAC CTG AAT GAA GAA GAT CCA ACA GTG TTG GAA TTG GGG ATC 360
361 ACT GGA AGT AAA TTT GAT GTA TCT TCA TTT AAC CCT CAT GGG ATT AGC ACA TTC ACA GAT 420
T G S K F D V S S F N P H G I S T F T D 122
421 GAA GAT AAT GCC ATG TAC CTC CTG GTG GTG AAC CAT CCA GAT GCC AAG TCC ACA GTG GAG 480
481 TTG TTT AAA TTT CAA GAA GAA GAA AAA TCG CTT TTG CAT CTA AAA ACC ATC AGA CAT AAA 540 
Analysis of DNA sequence
Comparing C2L2 cDNA sequence with the databases in the GenBank and EMBL, we found the major sequence was highly homologous to aryl-dialkyl-phosphatase (Fig 6) . Aryl-dialkyl-phosphatase was a gene with two polymorphic sites [6, 7] in accord with our results. There were three kinds of reported sequence [8] , whose length was 1576, 1217, 1337 bp respectively. They were all highly homologous to C2L2, but the sequence of C2L2 was the longest, which was 2,395 bp. Because C2L2 and these matched cDNA clones shared the same coding sequence, we concluded that they were the same gene.
Protein database searches of C2L2 indicated that N-terminal sequences showed similarity to other protein secretion signal peptide sequences (Fig 7) . Conservation of specific amino acids was apparent, but particularly interesting were the conserved three amino acid residues LAL that were contained by some protein sequences in their hydrophobic core region. Hydrophobicity analyses performed with PROSIS software according to the Hopp algorithm clearly showed the hydrophobic amino termini of C2L2 (Fig 8) .
DISCUSSION mRNA DD technique applied to isolate differentially expressed genes
To identify and isolate those genes that are differentially expressed in normal tissue versus tumor tissue is crucial to an understanding of the genetic aspect of tumorigenesis. The mRNA DD technique offers a novel, rapid method to this research. In spite of many advantages of mRNA DD in the analysis of altered gene expression, the major disadvantage of this technique is to generate high numbers of 'false positives'. In our experiment, we find two out of twenty-eight clones are 'true positive' and one of them is to be further characterized. These artifacts could be caused due to the following reasons: firstly, PCR itself may give some artifact results. Secondly, cDNA recovered from what may appear to be a unique band may contain additional, undeteetable overlapping, or unresolved cDNA. Contaminating cDNA might have been copurified with differentially displayed cDNA. Thirdly, some observed bands arise as a result of the amplification of cDNA sequences primed by only one of the two primers used in the PCR. This may result from the A-T rich nature of the 3' untranslated region of many genes, which can be recognized by the anchored primer. Besides, the sequence of arbitrary and its inverse-complement may exist in the same cDNA, resulting in the amplification of a region of cDNA between these two positions. Now an improved mRNA DD technique[9] is being established for analyzing differentially expressed cDNA clones from normal liver and hepatic cancer tissue.
The genetic polymorphism of the poison metabolizing enzymes-one of the important aspects of genetic susceptibility to cancer
Only a small number of individuals exposed to any given level of carcinogens will develop cancer. Interindividual differences in the susceptibility to these environmental exposures have been postulated. In fact, almost each phase of the multistage processes of carcinogenesis may be putatively modified by inherited or acquired interindividual differences in susceptibility. There are many demonstrable interindividual differences in the metabolic capability to convert proearcinogens to carcinogens and to detoxify carcinogens. These genetically determined differences result in variations in host susceptibility [10] . Polymorphic genes that encode for human biotransformation enzymes and affect the rate of metabolism of certain drugs and xenobiotics have been identified as one determinant of the susceptibility to environmental toxic chemicals. For example, GST M1 is an important phase II biotransformation enzyme and it detoxifies AFB1-2, 3-epoxide, which is the terminal carcinogen of AFB1. GST M1 possesses three genotypes: GST M1a, GST M1b, GST M1-null [11] . Individuals with a homozygous GST M1-null type express no protein so that they do not have the ability to detoxify AFB1-2, 3-epoxide. It has been suggested that this genotype should be associated with an increased risk of hepatic cancer. Recently Sheng et al have reported that N-acetyltransferase involved in detoxifying a number of poisons is associated with the susceptibility of hepatic cancer [12] . But there is no conclusion yet about which carcinogen is involved in hepatocarcinogenesis.
Aryl-dialkyl-phosphatase is a kind of esterase with a broad substrate specificity [13] Its substrates include aromatic carboxylic acid esters, carbamic esters and esters of phosphorus acid. This kind of esterase may have a prominent role in the metabolism of several toxic, synthetic compounds. But its endogenous substrates remain unknown and its physiological role has not yet been identified. According to results from our laboratory and other laboratories, aryl-dialkyl-phosphatase is also a type of polymorphic poison metabolic enzyme [6, 7] . Three phenotypes (Type A, Type B, Type AB) have been found to be controlled by two major alleles at a single autosomal locus. Sequencing of the coding region revealed that an Arg/Arg homozygote is associated with the high-activity phenotype (Type A), a Gln/Gln with the lowactivity phenotype (Type B), and an Arg/Gln heterozygote with the intermediate phenotype (Type AB). When the phenotype of this esterase is of low-activity, the ability to detoxify poison decreases significantly. According to long-term studies, the well-established environmental triggers for hepatocarcinoma include hepatitis B virus (HBV), hepatitis C virus (HCV), aflatoxin, nitrosamine, microcystin, ethanol and so on. At present, we are not sure whether other environmental chemical carcinogens might be involved in hepatocarcinogenesis and their metabolic processes do require aryl-dialkyl-phosphatase. However, a recent report has described that the development of hepatocarcinoma may be linked to the excessive exposure of organophosphate. As we described above, the aryl-dialkyl-phosphatase may be suppressed in its expression in hepatic cancer tissue as well as the non-cancerous liver tissue. It could be postulated that the downregulated expression of this enzyme in liver cells due to some factors (viral or others) could lead to the impairment of metabolic defensive mechanism to detoxify the organophosphate toxins, thereby rendering liver cells susceptible to carcinogen challenge. Moreover, an alternative hypothesis of the impairment in the esterase-dependent immune surveillance system related to the development of lymphoid tumor was recently postulated. It is suggested that the development of lymphoma is correlated to the exposure of organophosphorus compounds. This hypothesis puts emphasis on the possible new mechanism of organophosphorus compound that may impair the esterase-dependent host immune system as well as cause chromosome aberration. Thereby the host cells are more susceptible to viral carcinogenesis. The latter postulation may give some insight in search for the correlation between regulation of aryl-dialkyl-phosphatase to detoxify organophosphorus compounds and the impairment of host immune system in human hepatocarcinogenesis.
